Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
06/2006
06/15/2006WO2006021000A3 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
06/15/2006WO2005113526A3 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one
06/15/2006US20060128749 Compounds
06/15/2006US20060128697 Disease associated with AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) flux; cognitive disorders, anxiety or depressive syndromes, neurodegenerative diseases; N-(2-{4-[(5,5-dioxido-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazin-7-yl)oxy]phenyl}ethyl)methanesulphonamide
06/15/2006US20060128687 Lactam glycogen phosphorylase inhibitors and method of use
06/15/2006CA2587936A1 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites
06/14/2006EP1669072A1 Benzothiazine and benzothiadiazine derivatives, process for their preparation and phamaceutical compositions containing them
06/14/2006CN1787994A 2,4,6-phenyl substituted cyclic ketoenols
06/14/2006CN1786003A Sulfur, nitrogen heterocyclic naphacyl imine cell compounds and its application in tumour cell
06/14/2006CN1785982A New benzothiazine and benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
06/14/2006CN1259321C Substituted benzene fused heterocycle herbicides
06/13/2006US7060828 Angiogenosis inhibitor; anticancer agents
06/13/2006US7060704 S-aminoalkylsulfonamides, e.g., 3-[4-(3-Chlorophenyl)piperazin-1-yl]propylsulfonyl-2,3-dihydro-1H-indole, used to lower IOP, improvi blood flow to the optic nerve head and the retina, provide neuroprotection, and treat retinal diseases, sleep disorders, depression, and other psychiatric disorders
06/10/2006CA2527585A1 New benzothiazine and benzothiadiazine derivatives, their preparation process and the pharmaceutical compounds that contain them
06/08/2006US20060122383 Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine
06/07/2006EP1666462A1 N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system
06/07/2006EP1664112A2 Chimeric gabab receptor
06/07/2006EP1664092A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
06/07/2006EP1664063A1 Substituted piperazines of azepines, oxazepines, and thiazepines
06/07/2006EP1664062A1 Isothiazoloquinolones and related compounds as anti-infective agents
06/07/2006EP1664046A1 Aza-quinolinol phosphonate integrase inhibitor compounds
06/07/2006EP1664038A2 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved i in vivo /i efficacy
06/07/2006EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
06/07/2006EP1663237A2 Fused ring heterocycles as potassium channel modulators
06/07/2006EP1663107A2 Rifamycin analogs and uses thereof
06/07/2006EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines
06/07/2006EP1259489B1 Aryl fused azapolycyclic compounds
06/07/2006CN1784402A Imidazo and thiazolopyridines as JAK3 kinase inhibitors
06/07/2006CN1781921A Compounds for treating impaired fundic relaxation
06/06/2006US7057046 Lactam glycogen phosphorylase inhibitors and method of use
06/06/2006US7057042 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
06/06/2006US7057036 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
06/06/2006CA2178974C Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor
06/01/2006WO2005118537A3 Arylpiperazine derivatives as adrenergic receptor antagonists
06/01/2006WO2005034940A8 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
06/01/2006US20060116512 3-Oxo-3,4-dihydro-2H-benzo[1,4]thiazine-6-sulfonic acid {3-[(R)-5-(6-methoxy-quinolin-4-yl)-2-oxo-oxazolidin-3-yl]-propyl}-amide; to treat bacterial infections specially drug resistant
06/01/2006US20060116390 Hepatitis c virus inhibitors
05/2006
05/31/2006EP1661898A1 Bicyclic piperazine compound and use thereof
05/31/2006EP1660077A1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
05/31/2006EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors
05/31/2006EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors
05/31/2006EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors
05/31/2006EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors
05/31/2006CN1780842A Crystals of quinolinecarboxylic acid derivative solvate.
05/31/2006CN1780835A Novel fused heterocycles and uses thereof.
05/31/2006CN1780663A 9-azabicyclo nonylene derivatives with a heteroatom at the 3-position as renin inhibitors
05/31/2006CN1257895C Isoxazoline derivative and herbicide comprising the same as active ingredient
05/31/2006CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
05/31/2006CN1257891C Nitrogenous five-membered ring compounds
05/30/2006US7053211 Process for the preparation of α-aminosubstituted carboxylic acid amides
05/25/2006US20060111569 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
05/25/2006US20060111367 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide
05/25/2006US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
05/25/2006US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases
05/24/2006EP1659114A2 Process for the preparation of bicyclo[3.2.1]octane fused with quinazoline derivatives
05/24/2006EP1658294A1 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof
05/24/2006EP1551850B1 2" oxo-voruscharin and derivatives thereof
05/24/2006CN1257169C Bicyclic imidazo-3-yl-amine derivatives
05/23/2006US7049437 Particularly a crystal of 2-(3-isoxazolyl)-3,6,7,9-tetrahydroimidazo(4,5-d) pyrano(4,3-b)pyridine phosphate monohydrate
05/23/2006US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor
05/23/2006US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis
05/23/2006US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity
05/23/2006CA2242494C Novel n-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties
05/18/2006WO2006053166A1 8h-imidazo[4,5-d]thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
05/18/2006WO2006053120A1 IMIDAZO-FUSED THIAZOLO[4,5-b]PYRIDINE BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
05/18/2006WO2006051704A1 Imine compound
05/18/2006WO2005110422A3 Treatment of diseases associated with altered level of amyloid beta peptides
05/18/2006US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type
05/18/2006US20060106020 Tetracyclic inhibitors of Janus kinases
05/18/2006CA2587667A1 Imine compound
05/17/2006EP1657244A1 2-thiaquinolizidines as glycosidase and glycosyltransferase inhibitors
05/17/2006EP1656140A1 Mitotic kinesin inhibitors
05/17/2006EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors
05/11/2006US20060100254 Thiazolyl-dihydro-indazole
05/11/2006US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt
05/11/2006US20060100221 5-[[(2,3-Difluorophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl) 1 methylethyl]amino]-thiazolo[4,5-d]pyrimidin-2(3H)-one; asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
05/10/2006EP1654258A1 Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands
05/10/2006CN1771050A Macrocyclic hepatitis c serine protease inhibitors
05/10/2006CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/10/2006CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/10/2006CN1255414C 2,4- dichlorophenoxy acetalimide derivatives of dithiazo pyridine with herbicidal activity and its herbicidal composition
05/09/2006US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents
05/09/2006CA2257646C Benzo[g]quinoline derivatives
05/04/2006US20060094743 Isoquinoline compounds and medicinal use thereof
05/03/2006EP1652839A2 Drug efflux pump inhibitor
04/2006
04/27/2006WO2006044869A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
04/27/2006WO2006044415A2 Carboxylic acid peri - substituted bicyclics for occlusive artery disease
04/27/2006WO2006044000A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease
04/27/2006US20060089363 Antibacterial agents
04/27/2006US20060089351 Neuropeptide receptor modulators
04/27/2006CA2584368A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
04/27/2006CA2583828A1 Carboxylic acid peri-substituted bicyclics for occlusive artery disease
04/27/2006CA2583667A1 Sulfonamide peri-substituted bicyclics for occlusive artery disease
04/26/2006EP1648872A2 Aryl fused azapolycyclic compounds
04/26/2006EP1648564A1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 152